Aip regulates cAMP signalling and GH secretion in GH3 cells

Endocrine-Related Cancer

Volumn 20, Issue 4, 2013, Pages 495-505

  Formosa, R ^a   Xuereb Anastasi, A ^a   Vassallo, J ^a,b  

^a UNIVERSITY OF MALTA   (Malta)

^b MATER DEI HOSPITAL   (Malta)

Author keywords

AIP; cAMP; Function; Pituitary tumours

Indexed keywords

CYCLIC AMP; FORSKOLIN; GROWTH HORMONE; LUCIFERASE; PHOSPHODIESTERASE;

AIP GENE; ARTICLE; CANCER SUSCEPTIBILITY; CELL STRAIN GH3; CONTROLLED STUDY; CYCLIC AMP RESPONSIVE ELEMENT; ENZYME INHIBITION; GENE; GENE ACTIVITY; GENE MUTATION; GENE OVEREXPRESSION; GENE SILENCING; GROWTH HORMONE RELEASE; HUMAN; HUMAN CELL; HYPOPHYSIS ADENOMA; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE;

AIP; CAMP; FUNCTION; PITUITARY TUMOURS;

ANIMALS; CELL LINE; COLFORSIN; CYCLIC AMP; GROWTH HORMONE; HELA CELLS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; RATS; RNA, SMALL INTERFERING;

EID: 84882783001     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1530/ERC-13-0043     Document Type: Article

References (30)

1. Beischlag TV, Morales JL, Hollingshead BD & Perdew GH 2008 The aryl hydrocarbon receptor complex and the control of gene expression. Critical Reviews in Eukaryotic Gene Expression 18 207-250. (doi:10.1615/ CritRevEukarGeneExpr.v18.i3.20)
2. Bolger GB, Peden AH, Steele MR, MacKenzie C, McEwan DG, Wallace DA, Huston E, Baillie GS & Houslay MD 2003 Attenuation of the activity of the cAMP-specific phosphodiesterase PDE4A5 by interaction with the immunophilin XAP2. Journal of Biological Chemistry 278 33351-33363. (doi:10.1074/jbc. M303269200)
3. Chepurny OG & Holz GG 2007 A novel cyclic adenosine monophosphate-responsive luciferase reporter incorporating a nonpalindromic cyclic adenosine monophosphate response element provides optimal performance for use in G protein-coupled receptor drug discovery efforts. Journal of Biomolecular Screening 12 740-746. (doi:10.1177/1087057107301856)
4. Daly A, Tichomirowa M, Petrossians P, Heliovaara E, Jefrrain-Rea M, Barlier A, Naves LA, Ebeling T, Harhu A, Raappana A et al. 2010 Clinical characteristics and therapeutic responses in patients with germ-line AIP mutations and pituitary adenomas: an International Collaborative Study. Journal of Clinical Endocrinology and Metabolism 95 E373-E383. (doi:10.1210/jc.2009- 2556)
5. Formosa R, Gruppetta M, Falzon S, Santillo G, DeGaetano J, Xuereb-Anastasi A & Vassallo J 2012 Expression and clinical significance of Wnt players and survivin in pituitary tumours. Endocrine Pathology 23 123-131. (doi:10.1007/s12022-012-9197-8)
6. Froidevaux MS, Berg P, Seugnet I, Decherf S, Becker N, Sachs L, Bilesimo P, Nygard M, Pongratz I & Demeneix BA 2006 The co-chaperone XAP2 is required for activation of hypothalamic thyrotropin-releasing hormone transcription in vivo. EMBO Reports 7 1035-1039. (doi:10.1038/sj.embor.7400778)
7. Horvath A & Stratakis CA 2008 Clinical and molecular genetics of acromegaly: MEN1, Carney complex, McCune-Albright syndrome, familial acromegaly and genetic defects in sporadic tumours. Reviews in Endocrine & Metabolic Disorders 9 1-11. (doi:10.1007/s11154-007-9066-9)
8. Igreja S, Chahal HS, King P, Bolger GB, Srirangalingam U, Guasti L, Chapple JP, Trivellin G, Gueorguiev M, Guegan K et al. 2010 Characterization of aryl hydrocarbon receptor interacting protein (AIP) mutations in familial isolated pituitary adenoma families. Human Mutation 31 950-960. (doi:10.1002/humu.21292)
9. Jiang LI, Collins J, Davis R, Lin KM, DeCamp D, Roach T, Hsueh R, Rebres RA, Ross EM, Taussig R et al. 2007 Use of a cAMP BRET sensor to characterize a novel regulation of cAMP by the sphingosine 1-phosphate/G13 pathway. Journal of Biological Chemistry 282 10576-10584. (doi:10.1074/jbc.M609695200)
10. Jiang LI, Collins J, Davis R, Fraser ID & Sternweis PC 2008 Regulation of cAMP responses by the G12/13 pathway converges on adenylate cyclase VII. Journal of Biological Chemistry 283 23429-23439. (doi:10.1074/jbc.M803281200)
11. Kang BH & Altieri DC 2006 Regulation of survivin stability by the aryl hydrocarbon receptor-interacting protein. Journal of Biological Chemistry 201 24721-24727. (doi:10.1074/jbc.M603175200)
12. Kazlauskas A, Poellinger L & Pongratz I 2002 Two distinct regions of the immunophilin-like protein XAP2 regulate dioxin receptor function and interaction with hsp90. Journal of Biological Chemistry 277 11795-11801. (doi:10.1074/jbc.M200053200)
13. Lania A, Mantovani G & Spada A 2001 G protein mutations in endocrine diseases. European Journal of Endocrinology 145 543-559. (doi:10.1530/eje.0. 1450543)
14. Lania AG, Mantovani G, Ferrero S, Pellegrini C, Bondioni S, Peverelli E, Braidotti P, Locatelli M, Zavanone ML, Ferrante E et al. 2004 Proliferation of transformed somatotroph cells related to low or absent expression of protein kinase a regulatory subunit 1A protein. Cancer Research 64 9193-9198. (doi:10.1158/0008-5472.CAN-04-1847)
15. Leontiou CA, Gueorguiev M, van der Spuy J, Quinton R, Lolli F, Hassan S, Chahal HS, Igreja SC, Jordan S, Rowe J et al. 2008 The role of the AIP gene in familial and sporadic pituitary adenomas. Journal of Clinical Endocrinology and Metabolism 93 2390-2401. (doi:10.1210/jc.2007-2611)
16. Melmed S & Conn PM 2005 Endocrinology: basic and clinical principles. 2nd edn. New York: Humana Press.
17. Nakata A, Urano D, Fujii-Kuriyama Y, Mizuno N, Tago K & Itoh H 2009 G-protein signalling negatively regulates the stability of aryl hydrocarbon receptor. EMBO Reports 10 622-628. (doi:10.1038/embor.2009.35)
18. Oesch-Bartlomowicz B, Huelster A,Wiss O, Antoniou-Lipfert P, Dietrcih C, Arand M, Weiss C, Bockamp E & Oesch F 2005 Aryl hydrocarbon receptor activation by cAMP vs dioxin: divergent signaling pathways. PNAS 102 9218-9223. (doi:10.1073/pnas.0503488102)
19. Ohta Y, Nakagawa K, Imai Y, Katagiri T, Kioke T & Takaoka K 2008 Cyclic cAMP enhances Smad-mediated BMP signaling through PKA-CREB pathway. Journal of Bone and Mineral Metabolism 26 478-484. (doi:10.1007/s00774-008-0850- 8)
20. de Oliviera SK, Hoffmeister M, Gambaryan S, Muller-Esterl W, Guimaraes JA & Smolenski AP 2007 Phosphodiesterase 2A forms a complex with the co-chaperone XAP2 and regulates nuclear translocation of the aryl hydrocarbon receptor. Journal of Biological Chemistry 282 13656-13663. (doi:10.1074/jbc. M610942200)
21. Pertuit M, Barlier A, Enjalbert A & Gerard A 2009 Signalling pathway alterations in pituitary adenomas: involvement of Gsa, cAMP and mitogen-activated protein kinases. Journal of Neuroendocrinology 21 269-877.
22. Pronko SP, Saba LM, Hoffman PL & Tabakoff B 2010 Type 7 adenylyl cyclase-mediated hypothalamic-pituitary-adrenal axis responsiveness: influence of ethanol and sex. Journal of Pharmacology and Experimental Therapeutics 334 44-52. (doi:10.1124/jpet.110.166793)
23. Ramirez JL, Castano JP, Torronteras R, Martinez-Fuentes AJ, Frawley LS, Garcia-Navarro S & Gracia-Navarro F 1999 Growth hormone (GH) releasing factor differentially activates cyclic adenosine 3′,5′- monophosphate- and inositol phosphate-dependant pathways to stimulate GH release in two porcine somatotroph subpopulations. Endocrinology 140 1752-1759. (doi:10.1210/en.140.4.1752)
24. San-Marina S, Han Y, Suarez Saiz F, Trus MR & Minden MD 2008 Lyl1 interacts with CREB1 and alters expression of CREB1 target genes. Biochimica et Biophysica Acta 1783 503-517. (doi:10.1016/j.bbamcr.2007.11.015)
25. Spindler SR, Crew MD & Nyborg JK 1989 Thyroid hormone transcriptional regulatory region of the growth hormone gene. Endocrine Research 15 475-493. (doi:10.3109/07435808909036349)
26. Suzuki S, Yamamoto I & Arita J 1999 Mitogen-activated protein kinase-dependant stimulation of proliferation of rat lactotrophs in culture by 3′,5′-cyclic adenosine monophosphate. Endocrinology 140 2850-2858. (doi:10.1210/en.140.6.2850)
27. Vierimaa O, Goergitsi M, Lehtonen R, Vahteristo P, Kokko A, Raitila A, Tuppurainen K, Ebeling TML, Salmela PI, Paschke R et al. 2006 Pituitary adenoma predisposition caused by germline mutations in the AIP gene. Science 312 1128-1230. (doi:10.1126/science.1126100)
28. Yamamoto KK, Gonzalez GA, Biggs WH & Montminy MR 1988 Phosphorylation-induced binding and transcriptional efficacy of nuclear factor CREB. Nature 334 494-498. (doi:10.1038/334494a0)
29. Yang J, Li X, Al-Lamki RS, Southwood M, Zhao J, Lever AM, Grimminger F, Schermuly RT & Morrell NW 2010 Smad-dependent and smad-independent induction of id1 by prostacyclin analogues inhibits proliferation of pulmonary artery smooth muscle cells in vivo. Circulation Research 107 252-262. (doi:10.1161/CIRCRESAHA.109.209940)
30. Zhang X, Odom DT, Koo SH, Conkright MD, Canettieri G, Best J, Chen H, Jenner R, Herbolsheimer E, Jacobsen E et al. 2005 Genome-wise analysis of cAMP-response element binding protein occupancy, phosphorylation, and target gene activation in human tissues. PNAS 102 4459-4464. (doi:10.1073/pnas. 0501076102)